Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second-generation, ...
Ultima Genomics today announced Francisco De La Vega, DSc, has joined the Company as Vice President, Germline Genomics & Distinguished Scientific Fellow. With over 25 years of leadership experience in ...
An established international forum draws ~850 participants from 60+ countries and broad sponsor/exhibitor support, enabling ...
Inside the human gut lives a hidden world of trillions of microbes – and Professor Sam Forster is exploring how they shape ...
Liquid handling solutions support NGS workflows by enhancing throughput, minimizing manual error and standardizing library ...
Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer ...
Key Takeaways - A recent white paper from PJM seeks to reframe the region’s resource adequacy debate around risk ...
Ellis Bio today announced that an independent evaluation by Roche, published in a new Tech Spotlight, found that the ...
EpiCypher® and New England Biolabs® (NEB®) today announced an expanded strategic partnership to co-develop next-generation ...
The Caris Lookback Program identified 13,293 patients potentially eligible for newly approved targeted therapies across 10 ...
Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results